TP53 and neoplasm: In summary, we present a novel mechanism for tumor-promoting functions of UHRF1 in retinoblastoma and provide an additional insight into how retinoblastoma cells may alleviate p53-mediated tumor suppression, with potential implications of UHRF1 targeting as an efficient strategy to improve the efficacy of current chemotherapy for retinoblastoma treatment.